RETRACTED: Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer.

Biomedicines · 2022 · PMC9032383 · PMID 35453545

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These TF-encoding genes manifest highly significant co-expression patterns across human tissues with P-bi-TAT target genes (ARCHS4 TFs Co-expression database in Human Tissues) and significantly affect the expression of P-bi-TAT target genes following targeted genetic perturbations of individual TF-encoding genes (database of TF Perturbations Followed by Expression).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

RETRACTED: Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α&lt;sub&gt;v&lt;/sub&gt;β&lt;sub&gt;3&lt;/sub&gt; Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer.

The sentences

RETRACTED: Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer.